COVID 19 Vaccine - Quartz

Moderna and other vaccine stocks fall after a top FDA official quits

Moderna and other vaccine stocks fall after a top FDA official quits

By

PublishedMarch 31, 2025

Moderna's bird flu vaccine has a problem

Moderna's bird flu vaccine has a problem

By

UpdatedFebruary 27, 2025

Doctors are noticing an uptick in vaccine hesitancy, survey finds

Doctors are noticing an uptick in vaccine hesitancy, survey finds

By

PublishedDecember 27, 2024

Top FDA vaccine official says RFK Jr. nomination is a chance for scientists to make the case for vaccines

Top FDA vaccine official says RFK Jr. nomination is a chance for scientists to make the case for vaccines

By

PublishedNovember 21, 2024

Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary

Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary

By

PublishedNovember 15, 2024

Pfizer is betting on next-gen cancer drugs to offset slowing demand for COVID vaccines

Pfizer is betting on next-gen cancer drugs to offset slowing demand for COVID vaccines

By

PublishedAugust 19, 2024

Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial

Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial

By

UpdatedJune 10, 2024

Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising

Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising

By

PublishedJune 3, 2024

Moderna just got FDA approval for its RSV vaccine — only its second product on the market

Moderna just got FDA approval for its RSV vaccine — only its second product on the market

By

PublishedMay 31, 2024

Ozempic supply trackers, bird flu vaccines, and Merck's future: Pharma news roundup

Ozempic supply trackers, bird flu vaccines, and Merck's future: Pharma news roundup

By

PublishedMay 31, 2024

Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding

Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding

By

UpdatedMay 30, 2024

Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles

Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles

By

PublishedMay 22, 2024

AstraZeneca aims increase its annual revenue by 75% in its post-COVID era

AstraZeneca aims increase its annual revenue by 75% in its post-COVID era

By

PublishedMay 21, 2024

The Dow jumps 100 points as the winning streak keeps going

The Dow jumps 100 points as the winning streak keeps going

By

Vinamrata Chaturvedi

UpdatedMay 10, 2024

Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi

Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi

By

UpdatedMay 10, 2024

AstraZeneca is pulling its COVID-19 vaccine

AstraZeneca is pulling its COVID-19 vaccine

By

UpdatedMay 8, 2024

Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales

Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales

By

UpdatedMay 2, 2024

Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales

Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales

By

UpdatedApril 15, 2024

Moderna paused its plans for a facility in Kenya because COVID-19 vaccine demand has plummeted

Moderna paused its plans for a facility in Kenya because COVID-19 vaccine demand has plummeted

By

PublishedApril 11, 2024

Advertisement